10:11 AM EDT, 04/11/2025 (MT Newswires) -- Lucid Diagnostics ( LUCD ) said Friday it closed its public offering of about 14.4 million common shares, including roughly 1.9 million shares issued pursuant to the exercise of the underwriters' overallotment option, at $1.20 per share.

The net proceeds of about $16.1 million will be used for working capital and general corporate purposes, according to the company, which is a unit of PAVmed ( PAVM ) .

Price: 1.23, Change: -0.02, Percent Change: -2.00